NASDAQ

Precision BioSciences, Inc. (DTIL)

♥ 541 Thanks from members

Live price chart, market sentiment, and community perspectives for Precision BioSciences, Inc. (NASDAQ: DTIL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dan VoytasFounder: David SchafferLeadership: James J. Mahoney (Interim CEO)Leadership: Sundar Ramanan (CSO)Holder: Bayer AGHolder: Fidelity Management and ResearchHolder: BlackRockARCUS Genome EditingIn Vivo Gene Editing CandidatesAllogeneic CAR-T Cell Therapies#DTIL#Precision BioSciences#ARCUS#Gene Editing#Biotech Stock